Literature DB >> 8406161

Xenobiotic metabolising enzyme expression in colonic neoplasia.

J A McKay1, G I Murray, R J Weaver, S W Ewen, W T Melvin, M D Burke.   

Abstract

The cytochrome P450, epoxide hydrolase, and glutathione S-transferase enzyme families play an important part in the metabolism of many carcinogens and anti-cancer drugs. The expression of two forms of cytochrome P450 (P450 1A and P450 3A), epoxide hydrolase and of the alpha, mu, and pi forms of glutathione S-transferase in normal colon, colonic adenomas, and adenocarcinoma of the colon were studied by immunohistochemistry. This allowed the precise cellular site and distribution of each enzyme to be determined. Expression of all the xenobiotic metabolising enzymes studied was almost wholly confined to the epithelial cells, whether in normal, adenoma or carcinoma samples, except that cytochrome P450 3A was also identified in mast cells and glutathione S-transferase pi was also present in chronic inflammatory cells. Cytochrome P450 was present in only a small proportion of normal colon samples, whereas epoxide hydrolase and glutathione S-transferase mu were identified in about half, and glutathione S-transferase alpha and pi in most normal samples. By contrast all the enzyme forms studied were expressed in virtually all adenomas and in over half the carcinomas. These results suggest that cytochrome P450 1A and cytochrome P450 3A are more specific markers of colonic neoplasia than epoxide hydrolase or glutathione S-transferases alpha, mu, and pi.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406161      PMCID: PMC1375461          DOI: 10.1136/gut.34.9.1234

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Interaction of anticancer drugs with hepatic monooxygenase enzymes.

Authors:  G A Le Blanc; D J Waxman
Journal:  Drug Metab Rev       Date:  1989       Impact factor: 4.518

2.  Differences in adult and foetal human cytochrome P-450 forms recognized by monoclonal antibodies with specificity for the P450III family.

Authors:  T S Barnes; M D Burke; W T Melvin
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium.

Authors:  P C Hayes; D J Harrison; I A Bouchier; L I McLellan; J D Hayes
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

Review 4.  Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

Authors:  F P Guengerich
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

5.  Expression of xenobiotic metabolizing enzymes in breast cancer.

Authors:  G I Murray; R J Weaver; P J Paterson; S W Ewen; W T Melvin; M D Burke
Journal:  J Pathol       Date:  1993-03       Impact factor: 7.996

Review 6.  Molecular properties and biological functions of microsomal epoxide hydrase.

Authors:  A Y Lu; G T Miwa
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

7.  Cytochrome P450 activity and distribution in the human colon mucosa.

Authors:  D J Stralka; H W Strobel
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

8.  Glutathione S-transferases in normal and cancerous human colon tissue.

Authors:  W H Peters; F M Nagengast; T Wobbes
Journal:  Carcinogenesis       Date:  1989-12       Impact factor: 4.944

9.  Implications for therapy of drug-metabolizing enzymes in human colon cancer.

Authors:  K Mekhail-Ishak; N Hudson; M S Tsao; G Batist
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

10.  Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism.

Authors:  P M Shaw; T S Barnes; D Cameron; J Engeset; W T Melvin; G Omar; J C Petrie; W R Rush; C P Snyder; P H Whiting
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

View more
  18 in total

1.  Loss of orally administered drugs in GI tract.

Authors:  Yogeshkumar Nanasaheb Gavhane; Adhikrao Vyankatrao Yadav
Journal:  Saudi Pharm J       Date:  2012-04-20       Impact factor: 4.330

2.  Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes.

Authors:  E S Guns; P L Bullock; M L Reimer; R Dixon; M Bally; L D Mayer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

Review 3.  Human colonocyte detoxification.

Authors:  W E Roediger; W Babidge
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

4.  Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel.

Authors:  A C Povey; C N Hall; A F Badawi; D P Cooper; P J O'Connor
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 5.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

6.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

7.  Influence of dietary fat type on benzo(a)pyrene [B(a)P] biotransformation in a B(a)P-induced mouse model of colon cancer.

Authors:  Deacqunita L Diggs; Jeremy N Myers; Leah D Banks; Mohammad S Niaz; Darryl B Hood; L Jackson Roberts; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

8.  Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study.

Authors:  Jolantha Beyerle; Andreana N Holowatyj; Mariam Haffa; Eva Frei; Biljana Gigic; Petra Schrotz-King; Juergen Boehm; Nina Habermann; Marie Stiborova; Dominique Scherer; Torsten Kölsch; Stephanie Skender; Nikolaus Becker; Esther Herpel; Martin Schneider; Alexis Ulrich; Peter Schirmacher; Jenny Chang-Claude; Hermann Brenner; Michael Hoffmeister; Ulrike Haug; Robert W Owen; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

9.  Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.

Authors:  Weicang Wang; Jun Yang; Jianan Zhang; Yuxin Wang; Sung Hee Hwang; Weipeng Qi; Debin Wan; Daeyoung Kim; Jia Sun; Katherine Z Sanidad; Haixia Yang; Yeonhwa Park; Jun-Yan Liu; Xinfeng Zhao; Xiaohui Zheng; Zhenhua Liu; Bruce D Hammock; Guodong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-01       Impact factor: 11.205

10.  Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa.

Authors:  Ina Bergheim; Christiane Bode; Alexandr Parlesak
Journal:  BMC Clin Pharmacol       Date:  2005-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.